- Registration &
The Institute of Liver Studies at King's College Hospital invites you to register your interest in this series of courses on the management of patients with chronic viral hepatitis.
The next one day course will be held on 17th May 2013 and feature a world-class faculty in a small group setting to discuss the latest developments and best practice in managing both Hepatitis B and Hepatitis C.
The meeting will take place in the heart of Central London at No.11 Cavendish Square the Home of The King's Fund.
Target audiences: the course will be of benefit for: consultants and senior trainees in Hepatology and Gastroenterology, and other specialists and allied professionals who work with these patient groups.
Please use the tabs above for more information and Register your interest. We hope you will join us.
Friday 17th May 2013.
No.11 Cavendish Square, London
The venue is a Grade II listed Georgian townhouse, with exceptional classic and modern spaces, The Course will use the Burdett Theatre; a new 248 seat conference space with quality and high specification of the facilities. www.11cavendishsq.com
English is the official language of the Kings Liver Course.
Dr Kosh Agarwal, Consultant Hepatologist & Transplant Physician/Lead for Hepatitis Institute of Liver Studies, King's College Hospital Foundation Trust/ King's Health Partners.
Dr Will Bernal, Consultant Intensive Care Physician and colleagues from the Institute of Liver Studies, Kings College Hospital.
Recording of the Course
A CD of the slides will be distributed shortly after the Course.
Thank you to all the Faculty for their contributions and the venue for their support.
Additionally, the organisers would like to thank the corporate sponsors who have offered unrestricted medical grants in support of the course.
The organisers value support from charities and corporate institutions with an interest in supporting patients with liver disease. Please contact the Course Secretariat to discuss option to be involved.
The objectives of the courses are to help participants to:
- gain an understanding of the current, expert management of patients with these conditions.
- gain an overview of ongoing trials and evolving therapies
- and provide good value for money!
The courses comprise of lectures from international experts in the field and case based discussions, focussing on what represents best clinical practice in 2013. It provides a unique opportunity for small group discussion of detailed practical management with experts in the field.
CPD: 5 points are usually awarded.
Friday 17th May
|Session 1||HCV in 2013||Chair: Prof Roger Williams||Institute of
|0930||Welcome||Dr Kosh Agarwal||Kings College Hospital, London, UK|
|Licensed Triple Therapy- a year of challenges and promises||Prof Geoff Dusheiko||Royal Free Hospital, London, UK|
|0950||The US experience - really easy!||Prof Doug Dieterich||Mont Sinai Hospital, New York, USA|
|1010||Discussion and 3 cases||with Drs Deepak Joshi, Suman Verma and Phaedra Tachtatzis|
|Session 2||Clinical Challenges||Dr Abid Suddle||Kings College Hospital, London, UK|
|1100||HIV & HBV/HBV Liver Disease||Prof Jurgen Rockstroh||University of Bonn, Germany|
|1120||Cirrhotic patient issues||Dr Tarik Asselah||Hospital Beaujon,University of Paris Diderot, France|
|1150||An overview of DAAs and timelines||Dr Kosh Agarwal||Kings College Hospital, London, UK|
|1210||Discussion and 3 cases||with Drs Ivana Carey, Ashley Barnabas and Kate Child's|
|1240||Lunch And Exhibits|
|Session 3||EASL Debrief:
New trials and what the future holds
|Dr Kosh Agarwal
||Kings College Hospital, London, UK|
|1340||Presentations from companies|
Dr Jonty Manuja,
Hepatitis Merck Sharp and Dohme
Dr Nadine Chamay,
Senior Scientific Advisor, Virology (HCV-HIV) Medical Affairs
Dr Michael Elliott,
Vice President, Medical Affairs, Gilead Sciences (Europe, Asia & Middle East)
Dr Michael Aboud,
Country Medical Lead, Janssen Therapeutics EMEA (UK & Ireland)
Boehringer Ingelheim Ltd
Dr Tokunbo Soyemi,
Senior Medical Liason Manager, Medical & Scientific Affairs - Virology
Bristol Myers Squibb
Dr Dimitar Tonev,
Disease Area Head, Virology
|Panel discussion||with Foster, Dieterich, Asselah, Forton and Foxton|
|Session 4||HBV, HCC||Dr Matthew Foxton
||Chelsea & Westminster and King's College Hospital, London|
|1540||New data on HBV - Overview||Prof Graham Foster||Barts and The London School of
Medicine and Dentistry, London
|1600||HCC - the future is now||Prof Augusto Villaneuva||Kings College Hospital, London, UK|
The Registration Fees for the Course are as follows:
|Early discounted rate prior to 30 April 2013||£75.00||(payment must be received prior to 14th May to retain the discount)|
|Standard and on site rate||£100.00|
|Professionals allied to medicine
(specialist nurses, physiotherapists, pharmacists, technicians and medical students)
|Early discounted rate prior to 30 April 2013||£40.00||(payment must be received prior to 14th May to retain the discount)|
|Standard and on site rate||£50.00|
The Course Fee includes access to the programme, refreshments, Certificate of Attendance and CD to be distributed shortly after the event.
- Registration for this Course is on-line ONLY.
- Our on-line system allows for payment by cheque, bank transfer, invoice or credit card.
- ALL PAYMENTS MUST BE RECEIVED PRIOR TO 17TH MAY 2013.
- If you require an invoice for your payment, please select the invoice option from the system and print off your own invoice.
- Bookings cannot be made by telephone.
A Cancellation Policy is in place:
- Cancellations should be made in writing to the Secretariat. E-Mail is acceptable.
- Cancellations received up to and including 30th April 2013: full refund minus 25% administration charge.
- Cancellation received from 1st May 2013: no refund.
- Approved refunds will be processed and issued 60 days after the Meeting.
For details on hotels near the venue, please click the following link
Joining Instructions will be issued by E-mail around 10 days before the Course.
Neither the Host, the Organisers nor the Course venue can accept responsibility for any loss or injury relating to participants. All participants are encouraged to obtain their own travel insurance policy to cover the unfortunate possibility of cancellation of Registration. A Cancellation Policy is in place as regards Registration (see above).
Or Contact Via:
Index Communications Meetings Service
28 Winchester Road
Tel: +44 1794 511332
We would like to keep you informed about this Course. By completing the reply form you are authorising the Organisers to add your postal and E-Mail addresses to the contact database.